Development and validation of a droplet digital PCR assay for the evaluation of PML-RARα fusion transcripts in acute promyelocytic leukemia
Xi-Wen Jiang,Si-Ze Chen,Xiao-Ya Zhu,Xiao-Xie Xu,Yue Liu,Xi-wen Jiang,Si-ze Chen,Xiao-ya Zhu,Xiao-xie Xu
DOI: https://doi.org/10.1016/j.mcp.2020.101617
IF: 3.285
2020-10-01
Molecular and Cellular Probes
Abstract:<p>Acute promyelocytic leukemia (APL) is an aggressive disease that requires prompt treatment. Promyelocytic leukemia protein-retinoic acid receptor α (<em>PML-RARα</em>) fusion genes resulting from reciprocal translocation are considered a molecular basis for diagnosing APL. Moreover, <em>PML-RARα</em> fusion gene testing is an essential tool for monitoring the response to therapy via minimal residual disease and providing a diagnosis before rapid disease progression in APL. The present study developed a novel droplet digital PCR (ddPCR) assay to rapidly detect two <em>PML-RARα</em> variants (bcr1 and bcr3) and compared its limit of detection (LOD) with quantitative PCR (qPCR). It was demonstrated that the LOD of ddPCR for <em>PML-RARα</em> reached 0.001%, and the evaluation of high copy number samples of <em>PML-RARα</em> by ddPCR correlated well with qPCR. Furthermore, clinical sample testing with ddPCR found that 34 and 24% samples were bcr-1-positive and bcr3-positive, respectively. However, according to qPCR, 30% of the samples were bcr1-positive and 20% were bcr3-positive. In addition, the concordance rate between ddPCR and qPCR reaction was 86%. While monitoring minimal residual disease, the <em>PML-RARα</em> mutation rate of three patients who recovered well decreased to 0.34%. However, one patient who was bcr3-positive and relapsed had a mutation rate of 13% while in remission, indicating that the bcr3 isoform may be an adverse prognostic factor affecting recovery. Therefore, the present results suggested that this novel ddPCR assay may be useful for monitoring and evaluating the treatment effects and prognosis of APL.</p>
cell biology,biochemistry & molecular biology,biochemical research methods,biotechnology & applied microbiology